Treatment of viral hepatitis C genotypes 1 and 2 by sofosbuvir and ledipasvir with or without ribavirin combination: A possible alternative to pangenotypic treatment in a low-income country?
Objectives: The aim of this study was to evaluate the efficacy and safety of sofosbuvir/ledipasvir ± ribavirin in Malagasy patients with hepatitis C virus genotypes 1 and 2, in real conditions. Patients and methods: This was a retrospective monocentric clinical study, carried out over a period of 3...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021-06-01
|
| Colecção: | International Journal of Infectious Diseases |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1201971221003738 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|